Showing results (271-280 of 658) with videos related to
Sort By:
Pageof 66
Journal of Neuro-Oncology|June 19, 2019
Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECTGabrielle Truitt, Haley Gittleman, Rebecca Leece, et al.Journal of Neuro-Oncology|June 25, 2025
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastomaPushan Dasgupta, Heather Lin, Gayatri Kumar, et al.Journal of Neurosurgery|August 27, 2021
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastomaYuzaburo Shimizu, Joy Gumin, Feng Gao, et al.Neuro-Oncology Advances|November 26, 2020
RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicineBrittany C Parker Kerrigan, Daniel Ledbetter, Matthew Kronowitz, et al.Neuro-Oncology|April 30, 2008
Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosisAkira Nakamizo, Toshiyuko Amano, Wei Zhang, et al.Neuro-Oncology Advances|October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memoryYisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecanCandelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.Journal of Proteome Research|March 5, 2010
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiationHuan He, Carol L Nilsson, Mark R Emmett, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 18, 2023
Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in GlioblastomaArpan De, John M Lattier, John E Morales, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanismsArnab Chakravarti, Michael G Erkkinen, Ulf Nestler, et al.Pageof 66